Millendo Therapeutics, Inc. (51) | Human Resources (30)
Browse by Subcategory
Recent Contracts
-
Tempest Therapeutics, Inc. Amended and Restated 2019 Equity Incentive Plan
(Filed With SEC on June 21, 2022)
-
Executive Employment Agreement, dated January 12, 2022, by and between the Company and Nicholas Maestas
(Filed With SEC on May 13, 2022)
-
Separation from Employment, by and between Millendo Therapeutics US, Inc. and Julia C. Owens, Ph.D., dated January 27, 2021
(Filed With SEC on March 29, 2021)
-
Consulting Agreement, by and between the Registrant and Jeffery Brinza, dated August 23, 2019
(Filed With SEC on November 13, 2019)
-
Executive Employment Agreement, dated January 12, 2022, by and between the Company and Samuel Whiting, M.D., Ph.D
(Filed With SEC on May 13, 2022)
-
Executive Employment Agreement, dated January 12, 2022, by and between the Company and Thomas Dubensky
(Filed With SEC on May 13, 2022)
-
Executive Employment Agreement, dated January 12, 2022, by and between the Company and Stephen Brady
(Filed With SEC on May 13, 2022)
-
Form of Stock Option Agreement under the 2017 Equity Incentive Plan
(Filed With SEC on March 29, 2022)
-
Employment Agreement, dated July 7, 2021, by and between the Company and Samuel Whiting, M.D., Ph.D
(Filed With SEC on July 7, 2021)
-
Employment Agreement, dated July 7, 2021, by and between the Company and Thomas Dubensky, Ph.D
(Filed With SEC on July 7, 2021)
-
Employment Agreement, dated July 7, 2021, by and between the Company and Stephen Brady
(Filed With SEC on July 7, 2021)
-
Amended and Restated Employment Agreement between Jennifer Minai-Azary and Millendo Therapeutics US, Inc., dated of January 27, 2021
(Filed With SEC on March 29, 2021)
-
Amended and Restated Employment Agreement between Louis Arcudi III and Millendo Therapeutics US, Inc., dated as of January 27, 2021
(Filed With SEC on March 29, 2021)
-
Separation Agreement, by and among Millendo Therapeutics, Inc. and Ryan K. Zeidan, dated January 25, 2021
(Filed With SEC on January 28, 2021)
-
Amendment to the Millendo Therapeutics, Inc. 2019 Equity Incentive Plan
(Filed With SEC on June 23, 2020)
-
Amendment to the Millendo Therapeutics, Inc. (formerly OvaScience, Inc.) 2012 Stock Incentive Plan
(Filed With SEC on June 23, 2020)
-
Employment Agreement between Christophe Arbet-Engels and Millendo Therapeutics US, Inc., dated as of February 5, 2020
(Filed With SEC on March 11, 2020)
-
Form of Inducement Nonqualified Stock Option Agreement subject to the terms of the 2019 Equity Incentive Plan
(Filed With SEC on March 11, 2020)
-
Form of Stock Option Agreement under the Sub Plan for French Residents under 2019 Equity Incentive Plan
(Filed With SEC on March 11, 2020)
-
Form of Inducement Nonqualified Stock Option Agreement subject to the terms of the OvaScience 2012 Stock Incentive Plan
(Filed With SEC on March 11, 2020)
-
Employment Agreement, by and between Millendo Therapeutics US, Inc. and Tamara Joseph, dated July 11, 2019
(Filed With SEC on November 13, 2019)
-
Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Ryan Zeidan, dated August 16, 2019
(Filed With SEC on November 13, 2019)
-
Form of RSU Grant Package under 2019 Equity Incentive Plan
(Filed With SEC on August 12, 2019)
-
Form of Option Grant Package under 2019 Equity Incentive Plan
(Filed With SEC on August 12, 2019)
-
Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Jeffery M. Brinza, dated May 23, 2019
(Filed With SEC on August 12, 2019)
-
Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Louis Arcudi III, dated June 19, 2019
(Filed With SEC on August 12, 2019)
-
Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Julia C. Owens, Ph.D., dated June 19, 2019
(Filed With SEC on August 12, 2019)
-
2019 Equity Incentive Plan
(Filed With SEC on June 13, 2019)
-
Form of Stock Option Agreement under the Millendo Therapeutics, Inc. 2012 Stock Incentive Plan
(Filed With SEC on April 1, 2019)
-
Millendo Therapeutics, Inc. 2012 Stock Incentive Plan, as amended
(Filed With SEC on April 1, 2019)